Luis Castelo-Branco

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages

International Journal of Molecular Sciences, 1 gennaio 2025

2) COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

ESMO Open, 4 maggio 2023

3) Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

Journal for ImmunoTherapy of Cancer, novembre 2022

4) Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology

ESMO Open, ottobre 2021

Facts & figures

Luis Castelo-Branco has coordinated or participated in 4 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 17 elements tag cloud:

COVID-19 (3) oncology (2) vaccination (2) aggressive variant prostate cancer (AVPC) (1) cancer (1) cytotoxicity, immunologic (1) immunogenicity, vaccine (1) immunotherapy (1) predictive (1) prognosis (1) prostate cancer (1) PTEN (1) RB1 (1) SARS-CoV-2 (1) targeting (1) TP53 (1) tumor suppressor genes (TSGs) (1)

Luis Castelo-Branco has coordinated or participated in 4 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 3 scientific journals:

ESMO Open (2) International Journal of Molecular Sciences (1) Journal for ImmunoTherapy of Cancer (1)

Luis Castelo-Branco has coordinated or participated in 4 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 13 co-authors being active in Ticino:

George Pentheroudakis (2) Silke Gillessen Sommer (1) Ricardo Pereira Mestre (1) Jessica Barizzi (1) Irene Testi (1) Fabio Turco (1) Ursula Vogl (1) Sara Merler (1) Martino Pedrani (1) Luigi Tortola (1) Jean-Philippe Theurillat (1) Giuseppe Salfi (1) Alessandro Nepote (1)

Luis Castelo-Branco has coordinated or participated in 4 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 21 most frequently used terms (excluding 28 not relevant terms) are here listed:

L.C. WORD CLOUD cancer (3) covid (2) joint (2) esmo-cocare (2) emerging (1) aggressive-variant-associated (1) tumor (1) suppressor (1) genes (1) prostate (1) stages (1) pandemic (1) implementation (1) oncology (1) checkpoint (1) sars-cov (1) oncovid (1) registries (1) bsmo (1) psmo (1) databases (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 28 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)